Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.

Revenue
+3.95%
EPS
+34.8%
Free cash flow
−7.09%
Total debt
+15.6%

Quarter to September 2026, against a year earlier

85.40 2.84 −3.22%
Market cap
$9.4B
P/E
22.8×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Revenue
3,471.00 3,458.00 3,368.00 3,437.00

+8 more quarters

Revenue Growth
3.95% 6.73% 6.31% 7.71%
Gross Profit
1,105.00 1,101.00 1,070.00 1,063.00
Operating Income
193.00 171.00 182.00 163.00
EBT
160.00 137.00 150.00 133.00
Income after Tax
123.00 103.00 112.00 101.00
Net Income Common
119.00 94.00 107.00 101.00
EPS (Diluted)
1.12 0.82 0.92 0.85
Shares (Diluted, Weighted)
112.54 114.39 116.06 121.72
Gross Margin
31.84% 31.84% 31.77% 30.93%
EBIT Margin
5.56% 4.95% 5.40% 4.74%
Net Profit Margin
3.43% 2.72% 3.18% 2.94%
EBITDA
279.00 255.00 263.00 244.00
EBIT
193.00 171.00 182.00 163.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 5 Nov 2026